The prostate is a walnut-sized gland located just below the bladder in men. It surrounds the top portion of the male urethra (the tube that transports urine and semen out of the body). The gland's main function is to produce semen (a thick fluid that nourishes and transports sperm). Prostate cancer (an abnormal, uncontrolled growth of cells originating in the prostate gland) is the most common cancer, and the third-leading cause of cancer deaths, among American men. About 1 man in 6 will be diagnosed with prostate cancer during his lifetime. Although about 80% of men who reach age 80 are found to have prostate cancer, this condition alone may not contribute to serious harm if it does not spread. The November 15, 2006, theme issue of JAMA on men's health includes several articles dealing with prostate cancer.
Grahic Jump Location
Doctors and medical groups do not agree on when men should be screened (routinely tested) for prostate cancer because of controversy about the benefits vs risks of early treatment. The most often used screening tests include
Digital rectal examination (DRE)—A doctor feels the prostate gland by passing a gloved finger into the patient's rectum to find hard or lumpy areas of the gland, which may represent an abnormality.
Blood test (to detect a substance called PSA, prostate-specific antigen)—It is important to understand that the test is not perfect. Many men with mildly elevated PSA levels can have noncancerous prostate enlargement, which is a normal part of aging, whereas men with prostate cancer may have normal levels of PSA.
Prostate cancer is a very individual-specific disease. Discussions between the patient and his doctor are important to decide about testing and treatment. Based on an individual's situation, additional tests may be considered.
Decisions regarding the best treatment for you depend on a number of factors. These include your age, life expectancy, overall health status, and the growth and spread of the tumor, along with your doctor's recommendations.
Watchful waiting (expectant management)—Conservative care involves watching for new signs or symptoms with regular checkups and testing.
Surgery—The most effective way to cure prostate cancer is to undergo a radical prostatectomy (removal of the prostate gland). This treatment can result in subsequent problems regarding impotency (difficulty having an erection) or incontinence (problems with control of urination).
Radiation therapy (treatment with high-energy x-rays to kill or shrink cancer cells)—There are 2 types of therapeutic approaches: external beam (radiation comes from outside the body) and brachytherapy (internal radiation from radioactive materials placed directly into the prostate).
American Cancer Societyhttp://www.cancer.org
American Urological Associationhttp://www.urologyhealth.org
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish.
Sources: American Cancer Society, American Association of Clinical Urologists, American Urological Association
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724.
TOPIC: CANCER
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.